Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
A better strategy for assessing CV risk | Cardiologist takes stand in Derek Chauvin trial | J&J vaccine concerns
Tuesday, April 13, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

New research points to a better strategy for cardiovascular risk assessment

The team sees significant potential in its findings, though they still hope to make the technique "simpler and more clinically implementable."

READ MORE >
Heart failure hospitalizations among young adults are getting more common and more expensive
Share on Twitter Share on Facebook Share on Linkedin

New research points to a better strategy for cardiovascular risk assessment

Share on Twitter Share on Facebook Share on Linkedin
Heart failure hospitalizations among young adults are getting more common and more expensive
The team sees significant potential in its findings, though they still hope to make the technique "simpler and more clinically implementable."
READ MORE >

How early marijuana use affects the heart later in life

Researchers used ultrasound imaging to examine the hearts of young adults who smoked marijuana and those who did not. Their full analysis was published in the Journal of Applied Physiology

READ MORE >
The new analysis, based on data from 1.6 million patients, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. Medical marijuana
Share on Twitter Share on Facebook Share on Linkedin

How early marijuana use affects the heart later in life

Share on Twitter Share on Facebook Share on Linkedin
The new analysis, based on data from 1.6 million patients, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. Medical marijuana
Researchers used ultrasound imaging to examine the hearts of young adults who smoked marijuana and those who did not. Their full analysis was published in the Journal of Applied Physiology
READ MORE >

Cardiologist takes stand in Derek Chauvin trial, says George Floyd’s death was ‘absolutely preventable’

Jonathan D. Rich, MD, a cardiologist at Northwestern Medicine, took the stand during one of the most widely watched murder trials in recent memory. He testified that multiple steps could have been taken to prevent George Floyd's death. 

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist takes stand in Derek Chauvin trial, says George Floyd’s death was ‘absolutely preventable’

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
Jonathan D. Rich, MD, a cardiologist at Northwestern Medicine, took the stand during one of the most widely watched murder trials in recent memory. He testified that multiple steps could have been taken to prevent George Floyd's death. 
READ MORE >

Johnson & Johnson COVID-19 vaccine being investigated for possible blood clot risk

The European Medicines Agency is investigating the issue with help from the FDA. At this stage, the group emphasized that it remains unclear if the Johnson & Johnson vaccine is associated with any specific blood clot risk.

READ MORE >
Covid vaccine
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson COVID-19 vaccine being investigated for possible blood clot risk

Share on Twitter Share on Facebook Share on Linkedin
Covid vaccine
The European Medicines Agency is investigating the issue with help from the FDA. At this stage, the group emphasized that it remains unclear if the Johnson & Johnson vaccine is associated with any specific blood clot risk.
READ MORE >

Featured Articles

Uninterrupted OAC therapy for PCI patients leads to cost savings, shorter lengths of stay

Putting OAC therapy on hold does have its own benefits, the authors wrote, but uninterrupted OAC therapy is still the better choice. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Uninterrupted OAC therapy for PCI patients leads to cost savings, shorter lengths of stay

Share on Twitter Share on Facebook Share on Linkedin
Putting OAC therapy on hold does have its own benefits, the authors wrote, but uninterrupted OAC therapy is still the better choice. 
READ MORE >

Abbott’s next-generation device for tricuspid heart valve repair gains CE mark approval

The device is only approved in the United States for investigational use at this time.

READ MORE >
approved approval
Share on Twitter Share on Facebook Share on Linkedin

Abbott’s next-generation device for tricuspid heart valve repair gains CE mark approval

Share on Twitter Share on Facebook Share on Linkedin
approved approval
The device is only approved in the United States for investigational use at this time.
READ MORE >

Metformin shows promise for treating polycystic kidney disease

Typically used to treat Type 2 diabetes, metformin may also provide value as a treatment option for a serious, potentially fatal kidney disease. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Metformin shows promise for treating polycystic kidney disease

Share on Twitter Share on Facebook Share on Linkedin
Typically used to treat Type 2 diabetes, metformin may also provide value as a treatment option for a serious, potentially fatal kidney disease. 
READ MORE >

From the Magazine

IVL Turns Standard Balloon Technology into a Powerful Calcium-disruption Tool

Can a disruptive technology from the past become the nemesis of calcified lesions in the future?

READ MORE >
Michael Savage
Share on Twitter Share on Facebook Share on Linkedin

IVL Turns Standard Balloon Technology into a Powerful Calcium-disruption Tool

Share on Twitter Share on Facebook Share on Linkedin
Michael Savage
Can a disruptive technology from the past become the nemesis of calcified lesions in the future?
READ MORE >

In Other News

FDA approves first-of-its-kind colonoscopy AI

The FDA has granted de novo classification to an AI software module that puts a second pair of eyes on colonoscopy videos in real time and is compatible with any endoscope.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first-of-its-kind colonoscopy AI

Share on Twitter Share on Facebook Share on Linkedin
The FDA has granted de novo classification to an AI software module that puts a second pair of eyes on colonoscopy videos in real time and is compatible with any endoscope.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme